The 340B Drug Pricing Program reached a record $66.3 billion in 2024. For TPAs managing these transactions, the opportunity has never been larger, but neither has the pressure.
Hospital 340B programs are under siege from three directions:
HRSA audits finding errors in 62% of reviews (FY2024)
Eligibility thresholds putting 425 hospitals at risk
And increasingly, hospitals are asking their TPAs a question that's hard to answer:
"What would HRSA find if they audited us tomorrow?"
TPAs process transactions brilliantly. But the market is demanding something more: proactive audit intelligence.
• • •
The Customer Expectation Gap
What Hospitals Want vs. What They Get
From KLAS Research (2024):
"Across vendors, customers want more help navigating drug manufacturer restrictions; automated tools and strong service are highlighted for easing provider burden."
From our research interviews and published commentary:
"A single hospital can easily have five TPAs and 70 contract pharmacies. They don't have all the pieces pulled together."
VytlOne, 2024
"Many 340B departments routinely identify data errors that TPAs fail to detect or resolve."
Pharmacy Times, 2024
Hospitals are doing their own auditing on top of TPA services. They're running manual sampling, hiring consultants, and building internal compliance teams, because they don't fully trust any single system to catch everything.
This isn't a TPA failure. It's a capability gap in the market that creates differentiation opportunity.
• • •
The Strategic Question
From Transaction Processing to Compliance Partner
What if a TPA could offer hospitals continuous audit intelligence, not just transaction processing?
Not replacing the core 340B engine. Extending it with:
→
Adversarial self-auditing that finds problems before HRSA does
→
Predictive eligibility forecasting with 6-18 month visibility
→
Defense brief generation for audit-ready documentation
→
Cross-system data validation that catches conflicts early
This is the capability we've designed: 340B Audit Intelligence Module: a white-label agentic AI layer that transforms TPA platforms from transaction processors into compliance partners.
• • •
The Research
What does 340B compliance actually involve?
HRSA Audit Findings (FY 2024)
Finding Type
Frequency
Root Cause
Incorrect OPAIS records
62%
Data synchronization, timing issues
Diversion findings
17%
82% involve contract pharmacy prescriptions
Duplicate discount findings
17%
91% tied to MEF inaccuracies
Required manufacturer repayment
18%
none
The pattern: Most findings stem from data accuracy, timing, and cross-system validation, exactly where an AI layer can add value.
The Hospital Compliance Burden
Manual sampling catches ~1% of transactions
70%+ of compliance team time spent on audit preparation
Eligibility problems often discovered at cost report filing, too late to remediate
Hospitals hiring external consultants to audit their TPAs
What Customers Are Asking For
From KLAS and industry research, hospitals want:
More proactive guidance on manufacturer restrictions
Better visibility into compliance posture
Audit-ready documentation without manual assembly
Confidence in eligibility determinations
• • •
The Module Concept
340B Audit Intelligence: A TPA Enhancement Layer
An agentic AI capability that sits on top of existing TPA infrastructure, adding continuous audit intelligence without replacing core transaction processing.
Five Autonomous Capabilities
Capability
What It Does
TPA Value
Continuous Auditor
Randomly samples and investigates transactions like HRSA would
Catches errors before they become findings
Data Validator
Cross-references TPA data against EHR, pharmacy, and registry sources
The module is designed for white-label deployment:
Deployment Options
Embedded Module: Full integration into TPA platform, TPA-branded
API Layer: Intelligence services called from existing TPA interfaces
Standalone Dashboard: Complementary interface for compliance teams
• • •
The Design Framework
Agentic AI Interface Design for High-Stakes Compliance
This module applies principles from our Agentic AI Interface Design framework, specifically developed for scenarios where autonomous systems must collaborate with human experts in high-consequence environments.
Three Design Paradigms
"Defensible Over Intuitive" Philosophy
In 340B compliance, users don't just need easy interfaces. They need interfaces they can explain to HRSA auditors.
For each flagged item, auto-generated HRSA-ready documentation:
Issue summary
Defensibility assessment
Supporting documentation checklist
Recommended narrative
Approval workflow
For TPA Account Teams
Customer Health Dashboard
Aggregate view across managed hospitals:
Program health scores by customer
Alert volume trends
Predicted audit risk tiers
Proactive outreach recommendations
Competitive Intelligence
Feature adoption metrics
Customer satisfaction correlation
Upsell opportunity identification
• • •
Business Case
The Differentiation Opportunity for TPAs
Current Market State
From KLAS Research:
Customers want more help with manufacturer restrictions
Automated tools highlighted as key differentiator
Strong service = competitive advantage
Vendor expansion creating growing pains
The Value Proposition
For TPA Revenue:
Premium tier upsell opportunity
Increased customer retention
Differentiation from commodity competitors
New services revenue stream
For TPA Customers:
Reduced audit prep burden
Proactive risk identification
Confidence in compliance posture
Defensible documentation
Pricing Model Options
Model
Description
Fit
Premium Tier
Include in top-tier TPA package
Drives upgrades
Per-Hospital Add-On
$X/month per covered entity
Incremental revenue
Percentage of Savings
Share of avoided audit costs
Aligned incentives
White-Label License
Annual platform fee
Enterprise deals
• • •
Risk Mitigation
What do TPAs usually worry about?
Concern:
"This implies our core product has gaps."
Response:
Every TPA processes transactions well. The gap is in proactive intelligence, a capability that doesn't exist anywhere in the market. First-mover advantage goes to TPAs who add it.
Concern:
"Integration complexity."
Response:
Designed for API-first deployment. Can start with standalone dashboard, progress to full integration.
Concern:
"Customer confusion with multiple interfaces."
Response:
White-label design. Customers see one branded experience, powered by intelligence layer underneath.
• • •
Implementation
How would this roll out?
• • •
About This Concept
A Research-Backed Proof of Concept
What This Is
A research-backed proof of concept demonstrating how agentic AI can extend TPA capabilities into proactive compliance intelligence.
It showcases 32°N's approach to:
Healthcare compliance UX design
Agentic AI interface architecture
"Defensible over intuitive" design philosophy
White-label module design for platform integration
What This Is Not
A production-ready product
Connected to real patient data
An FDA-regulated medical device
A TPA replacement
The Conversation We Want to Have
If you're building or operating a 340B TPA platform, we'd like to explore:
What are your customers asking for that you can't deliver today?
How do you differentiate from commodity competitors?
Where does "audit readiness" fit in your roadmap?
What would proactive compliance intelligence be worth as an upsell?
They already shipped with us
Ready to turn 11% adoption into 68%?
Thirty minutes. We will tell you what is actually broken, and whether we are the right people to fix it. We've told people to build internally when that made more sense.
